top of page

About
- Corporate Overview
- Executive Management
Science
- Limbic Stem Cells & Exosome
- DNA Methylation Analysis
Services
Pipeline
- Cancer Detection
- Eye Related
Social Responsibility
Newsroom
Contact
More

Use tab to navigate through the menu items.

Newsroom

All Posts
Publication
News

Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer

Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer

Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer

Frontiers in oncology vol. 12 1004261 Muhamad Ansar, Le Thi Anh Thu, Chin-Sheng Hung, Chih-Ming Su, Man-Hsu Huang, Li-Min Liao, Yu-Mei...

Nov 7, 2022

A Three-Dimensional Bioprinted Copolymer Scaffold with Biocompatibility and Structural Integrity for Potential Tissue Regeneration Applications

A Three-Dimensional Bioprinted Copolymer Scaffold with Biocompatibility and Structural Integrity for Potential Tissue Regeneration Applications

A Three-Dimensional Bioprinted Copolymer Scaffold with Biocompatibility and Structural Integrity for Potential Tissue Regeneration Applications

Polymers 14, no. 16: 3415 Peng, Bou-Yue, Keng-Liang Ou , Chung-Ming Liu, Shu-Fen Chu, Bai-Hung Huang, Yung-Chieh Cho, Takashi Saito,...

Aug 21, 2022

Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer

Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer

Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer

Molecular medicine (Cambridge, Mass.) vol. 28,1 67 Lin, Ruo-Kai , Chih-Ming Su , Shih-Yun Lin , Le Thi Anh Thu , Phui-Ly Liew , ...

Jun 17, 2022

Contact

17 F., No. 3, Yuanqu St., Nangang Dist.,

Taipei City 115603, Taiwan (R.O.C.)

Email: service@udn-pharm.com

Tel: +886-2-2382-0330

Menu

Products & Services

Social Responsibility

bottom of page